BH

Investor - NFA, DYOR. OU fan - BOOMER

[BH @bEz1023]

@mk12856907 From what I’ve seen, concerns around declining Medicaid enrollment and higher utilization.

[BH @bEz1023]

Worth reposting. I just ran through $CNC's earnings transcript and their glowing ACA commentary is likely what's driving $OSCR's rebound today (and/or Piper Sandler raise from $26 to $36).

They raised Marketplace margin guidance to 4.5-5%, saying utilization moderated, risk adjustment came in better than expected, and 2026 pricing proved stronger than they initially thought.

They also called the ACA Marketplace a "compelling future-proof platform," said they expect normalized growth after the current policy changes, and highlighted 2.5x YoY ICHRA growth while remaining bullish on the opportunity.

Given its sector leading performance in several critical metrics to start the year, all of this reaffirms my bullish stance on $OSCR heading into Q2 earnings. Buckle up.

[Invest with AC @investingwithac]

PIPER SANDLER RAISES $OSCR PRICE TARGET TO $36 FROM $26

“Oscar Health appears insulated from broader Marketplace pressures affecting peers, with favorable membership trends, pricing dynamics, and expected Q2 upside supported by risk adjustment outperformance”

https://t.co/ZGodKqdQZf

[BH @bEz1023]

Liking the sound of this for $OSCR

[BMS Finance Grad @degeninvestor7]

$CNC has been very bullish on the ACA marketplace during the earnings call

-Expects ACA to be a stable business segment over the next several years
-Wakely June claims report favorable
-Raised guidance based on ACA strength

Bullish for $OSCR

[BH @bEz1023]

@obfuscated_id Hopefully the inverse doesn’t hold true for $OSCR, with healthier members raising MLR due to greater utilization of its risk adjustment accrual.

[Invest with AC @investingwithac]

$OSCR

It is now a waiting game.

All signs point to a massive beat.

[obfuscated @obfuscated_id]

Buying a stock breaking out of a long base on fundamentals like more members, better retention, better pricing power, increased margins, profitability, great management and execution, on its first real consolidation on the 50 day moving average is a powerful historical setup in growth stocks.

Pick a few and look back! $OSCR

[BH @bEz1023]

@investingwithac 🫡

[BH @bEz1023]

Barclays agrees. $OSCR

[Invest with AC @investingwithac]

$OSCR dumping after hours on $MOH report…

MOH’s Marketplace MCR jumped to 88.9%, driven by unfavorable acuity, NEGATIVE prior-year risk adjustment and program integrity initiatives.

For $OSCR , this does not necessarily matter, as $MOH largely exited the ACA and took on unhealthy members, THEN got hit with a massive NEGATIVE prior year risk adjustment report.

Meanwhile, $OSCR received a POSITIVE $130 million adjustment, which is HUGE, and over-accrued 236 million of risk adjustment in Q1.

The key for $OSCR wasn’t just Marketplace membership growth, but AI efficiencies and tech-first infrastructure.

It’s who you enroll, how accurately you price them, and managing risk adjustment.

This is why $OSCR was so efficient in Q1, they got pricing RIGHT, went conservative on risk adjustment, dominated open enrollment, and are now about to show how important it is to have an industry veteran like Mark Bertolini…

Again, $MOH ‘s poor performance in the marketplace was due to a negative risk adjustment hit from 2025, poor member retention from exits, and being left with unhealthy members which rose their medical costs. All operational.

This does not impact the $OSCR bull case one single bit, if anything, makes me more bullish.

$OSCR ‘s 2026 execution was equivalent to prime MJ.

[Sparkita Capital Research @SparkitaCR]

$OSCR

[BH @bEz1023]

The good news just keeps coming for $OSCR and it isn’t coincidence, it’s execution. Rotation into healthcare is real for a reason.

[Invest with AC @investingwithac]

$OSCR

“Baird believes the 2025 healthcare exchange risk adjustment factor true-up looks favorable for Centene ( $CNC ) and Oscar Health ( $OSCR ) and a “slight headwind” for Molina Healthcare ( $MOH ).”

https://t.co/N0kPIWeGUL

[BH @bEz1023]

No concerns with $OSCR based on this prearranged sale from months ago given all of the positive financial trends and commentary from management this year.

[Invest with AC @investingwithac]

$OSCR

Mark B, CEO of Oscar Health sells shares to satisfy tax withholding obligations

“Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units and time-based restricted stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026.”

[The Long Investor @TheLongInvest]

$OSCR This is the exact same chart we shared on Christmas Day

Same support levels
Same price targets
Same impulse count
Same conviction

We did all the work for you
Your job was to just buy and hold.

$OSCR will have no issue hitting $45

$ZETA will also do the same.

[BH @bEz1023]

@growthrapidly Bought my biggest lot last July at $16.75 and my 2nd largest a few months back at $11.80. Not selling anytime soon. We’re just getting started!

[BH @bEz1023]

The team matters. Execution by $OSCR leadership across multiple mission critical levers is undeniable. Look for continued bottom line impact in the quarters and years to come.

[Invest with AC @investingwithac]

$OSCR PASSES $30 FOR THE FIRST TIME IN YEARS

[The Long Investor @TheLongInvest]

$OSCR now at $30

PT next is $45

I don’t think I’ve been obnoxious enough about these gains

Maybe this is progress

[Invest with AC @investingwithac]

$OSCR

“the market is positioned for 2-3x industry-wide growth in 2027”

[BH @bEz1023]

@investingwithac I thought I remembered hearing the same but couldn’t track it down. Thanks! 🫡

[BH @bEz1023]

Well said. Hard to argue against the leverage AI has created for $OSCR - members & revenue have exploded and employee count hasn’t. Despite this - members rate their experience significantly higher than the industry average.

Explosive growth + member retention = disruptor for years to come.

[WaveInvestor @InvestorSince21]

The financial setup is even more compelling than the growth numbers suggest.

$OSCR is seeing real operating leverage: better pricing discipline, favorable risk mix, fixed-cost leverage, and AI efficiencies across claims and member services.

It enters 2026 with a fortress balance sheet ($ 4.83B+ in cash & restricted cash) and is guiding strong margin expansion while growing revenue ~60%. The individual market remains resilient, and Oscar’s ICHRA and broker tools position it to capture share from both consumers and employers shifting away from traditional group coverage.

(3/4)

[BH @bEz1023]

@darrelltalksfi Not buying a house and investing was an absolute game changer for me. Current RE market conditions make this a no brainer - rent, invest and then buy the block later.

[BH @bEz1023]

$OSCR isn’t just another stock being pumped on X. Its leadership has a proven track record of gaining market share and driving considerable value appreciation, because each move made is with their members in mind.

Each of these catalysts outlined by @investingwithac will serve as growth drivers for @OscarHealth in an industry that has experienced a shift from prior year headwinds to tailwinds in 2026.

While growing institutional ownership, analyst upgrades and price appreciation reflect this shift in sentiment, plenty of runway still exists with continued execution.

[Invest with AC @investingwithac]

$OSCR

Currently trading at 0.458x P/S of 2026 guidance

250-450 million guide on profitability

PLUS new 130 million positive PPD

380-580 million earnings from operations

PLUS morbidity tracking better than expected

Lets assume just over the higher end, at 650 million

650/19000=3.42% Op Margins…

If 5% margins imply 1x P/S or higher…

Then 3.42% margins imply 0.68x P/S or higher… MINIMUM

That implies a 48.57% price increase to $41.57… MINIMUM

This doesn’t account for a premium given from Lucie, +Oscar, ICHRAx, or the potentially for even higher operating margins in 2026…

This also doesn’t account for 5% margins to likely happen in 2027…

This doesn’t account for competitors leaving the marketplace, which Oscar has overlap with and picks up those members…

This doesn’t account for the fact that ICHRA is becoming increasingly adopted…

This doesn’t account for the fact that we will likely trade higher than recently across the board due to increasingly favorability on insurers…

This also doesn’t account for the fact that $OSCR is one of, if not the, fastest growing health insurance company in the US.

I am Long $OSCR , at $10-13 this was the “mother of all buys”, and at $28, it’s a good DCA, but not “all-in”…

I do what I say. I have daily purchases currently, and will add heavier on dips.